This paper examines the biological and cellular mechanisms underlying cancer development, moving beyond environmental risk factors to analyze the molecular processes that initiate and promote tumor growth. The paper synthesizes research on inflammation as a cancer mediator, the role of oncogenes and tumor suppressors in malignant transformation, the p53 protein's function in DNA damage response, and how free radicals and oxidative stress contribute to genetic mutations. By integrating findings from multiple studies on intrinsic and extrinsic pathways, the paper demonstrates that cancer results from complex interactions between genetic alterations, inflammatory signaling, and cellular stress responses.
The American Cancer Society estimated 1,529,560 cases of cancer in the United States in 2010. Numerous individuals have succumbed to the disease, and the causes of cancer range from environmental to biological. Environmental factors play a substantial role in cancer development: tobacco accounts for 30% of cancer deaths, causing cancer of the lung, oral cavity, esophagus, and stomach. Diet and lifestyle also influence cancer risk; maintaining healthy habits can reduce the chances of breast and colon cancer. Excess weight increases the production of estrogen and insulin, which in turn promotes cancer growth. Alcohol increases the incidence of cancers of the throat, liver, breast, colon, and rectum by acting as an irritant to body tissues. When cells are damaged, this impairs their ability to repair DNA damage. Excess alcohol consumption may cause liver inflammation, which can then increase cancer incidence. While environmental factors are significant, cancer is ultimately a product of abnormal gene function. Genes are part of DNA, and when DNA changes, a mutation is created, which can be inherited or acquired.
Research has established a direct link between inflammation and cancer development. In a study led by Schetter (2009), investigators found that the "key mediators of inflammation-induced cancer include nuclear factor kappa B, reactive oxygen and nitrogen species, inflammatory cytokines, prostaglandins and specific microRNAs" (p. 37). Inflammation creates instances of tumor activity, which generates "cell proliferation, cell death, cellular senescence, DNA mutation rates, DNA methylation and angiogenesis" (Schetter, 2009, p. 37). Inflammation operates through two distinct pathways that may lead to cancer: extrinsic and intrinsic pathways.
In the extrinsic pathway, cancer risk is elevated due to chronic infection or inflammation derived from external sources. In the intrinsic pathway, cancer is driven by genetic modifications of oncogenes and tumor suppressors. Chronic inflammation increases the levels of reactive oxygen and nitrogen species (RONS), which leads to DNA strand breaks, resulting in point mutations and aberrant DNA cross-linking. These alterations modify protooncogenes and tumor suppressor genes, ultimately creating cancer.
Oncogenes play a central role in cancer by undergoing modifications and alterations that transform normal cells into malignant ones. In Croce's (2008) research, he noted that oncogenes "encode proteins that control cell proliferation, apoptosis, or both. They can be activated by structural alterations resulting from mutation or gene fusion. Translocations and mutations can occur as initiating events or during tumor progression" (p. 503). Oncogenes can be classified into six functional categories: transcription factors, chromatin remodelers, growth factors, growth factor receptors, signal transducers, and apoptosis regulators (Croce, 2008, p. 503).
Oncogenes are activated through three primary mechanisms: chromosomal rearrangements, mutations, and gene amplification. Mutations in oncogenes alter the encoded protein, resulting in "carcinomas of the lung, colon, and pancreas, as well as acute myelogenous leukemia and the myelodysplastic syndrome" (Croce, 2008, p. 507). Gene amplification provokes oncogene initiation when "different oncogene families are often amplified in small-cell lung cancer, breast cancer, esophageal cancer, cervical cancer, ovarian cancer, and head and neck cancer" (Croce, 2008, p. 507). These mechanisms demonstrate how a single altered gene can promote cancer across multiple tissue types through the overproduction of cancer-promoting proteins.
The proto-oncogene p53 is a critical cellular guardian against cancer. According to Harris (1986), p53 "is a cellular protein expressed at low levels in nontransformed cells. In contrast, in tumor-derived and transformed cell lines, the levels of p53 are often elevated" (p. 4650). When DNA damage occurs, p53 is activated and responds "with an increase in its levels and with an increased ability of p53 to bind DNA and mediate transcriptional activation. This then leads to the activation of a number of genes whose products trigger cell-cycle arrest, apoptosis, or DNA repair" (Lakin, 1999, p. 7644). By inducing these protective mechanisms, p53 prevents damaged cells from progressing to malignancy, earning it the designation as a tumor suppressor.
Free radicals represent another critical pathway to cancer by directly damaging cellular components. In research led by Hussain, investigators identified the primary targets of free radicals: DNA, proteins, RNA, and lipids. Hussain noted that "mutations in cancer-related genes or post-translational modifications of proteins by nitration, nitrosation, phosphorylation, acetylation or polyADP-ribosylation by free radicals or lipid peroxidation byproducts are some of the key events that can increase cancer risk" (Hussain, 2003, p. 276). Free radical damage operates at the molecular level to alter the very genes and proteins that normally protect cells from malignant transformation.
Nitric oxide (NO) represents a particularly important free radical mediator in chronic inflammation. Hussain (2003) found that p53 acts as a stress mediator, but NO "causes p53 accumulation and post-translational modifications that inhibit cellular growth" (p. 278). His research revealed that chronic exposure to NO in the absence of functional wild-type p53 may increase cancer risk due to inadequate regulation of inducible nitric oxide synthase (iNOS). Cellular vulnerability to oxidative stress also depends on genetic variation in antioxidant enzymes. The "polymorphism of the gene encoding the antioxidant enzyme manganese superoxide dismutase (MnSOD), which converts O2 to H2O2, alters protein trafficking" (Hussain, 2003, p. 282) and increases breast cancer risk. Similarly, lung cancer risk is elevated by the "polymorphism at Pro198LEU in the glutathione peroxidase 1 gene—which converts H2O2 to water" (Hussain, 2003, p. 282). These genetic variations limit the cell's ability to neutralize oxidative damage, increasing mutation risk.
The concern for cancer is ever growing and no one is immune to such a disease, which can take place anywhere in the body due to abnormal cell growth. However, certain environmental factors may be modified to reduce risk, such as eating better and becoming more active while discarding a smoking habit. Genetics plays a role and family history of cancer potentially increases one's risk. Studies have demonstrated that cancer arises through multiple interacting mechanisms, ranging from inflammation to free radical damage, each operating at different biological scales but ultimately converging on altered genes and proteins that drive malignant transformation.
You’re 97% through this paper. Sign up to read the full paper.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.